MedTrace Logo

Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic

NCT01703910 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2015-10-09

No results posted yet for this study

Summary

The purpose of this study is to assess the feasibility of selecting personalized therapies for colon cancer patients who have failed standard treatments, using a new methodology based on the determination of a profile of chemosensitivity by comprehensive genetic expression analysis from tumor samples.

Conditions

Interventions

DRUG

Arm A chemotherapy

DRUG

arm B chemotherapy

Sponsors & Collaborators

  • Hospital Universitario de Fuenlabrada

    collaborator OTHER

  • Grupo Hospital de Madrid

    collaborator OTHER

  • Apices Soluciones S.L.

    collaborator INDUSTRY

  • Centro Nacional de Investigaciones Oncologicas CARLOS III

    lead OTHER

Principal Investigators

  • Carlos Gómez, M.D.,Ph.D · Centro Nacional de Investigaciones Oncológicas (CNIO)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
76 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2012-11-30
Completion
2014-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01703910 on ClinicalTrials.gov